Holen Sie sich die Stockscreener-App
2.76
6.44%
-0.19
Handel nachbörslich:
2.63
-0.13
-4.71%
Schlusskurs vom Vortag:
$2.95
Offen:
$2.82
24-Stunden-Volumen:
137.01K
Relative Volume:
3.33
Marktkapitalisierung:
$11.37M
Einnahmen:
$98,000
Nettoeinkommen (Verlust:
$-86.59M
KGV:
-0.5064
EPS:
-5.45
Netto-Cashflow:
$-48.49M
1W Leistung:
-21.81%
1M Leistung:
-51.89%
6M Leistung:
-62.24%
1J Leistung:
-85.40%
1-Tages-Spanne:
$2.38
$2.84
1-Wochen-Bereich:
$2.38
$3.5999
52-Wochen-Spanne:
$2.38
$19.90
Biora Therapeutics Inc Stock (BIOR) Company Profile
Firmenname
Biora Therapeutics Inc
Sektor
Branche
Telefon
855-293-2639
Adresse
4330 LA JOLLA VILLAGE DRIVE, SAN DIEGO
Biora Therapeutics Inc Aktie (BIOR) Neueste Nachrichten
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
SEC Form 424B5 filed by Biora Therapeutics Inc. - Quantisnow
SEC Form 424B3 filed by Biora Therapeutics Inc. - Quantisnow
Biora Therapeutics announces $3 million stock and warrant sale - Investing.com India
Biora Therapeutics advances oral drug delivery tech By Investing.com - Investing.com Nigeria
Biora Therapeutics advances oral drug delivery tech - Investing.com India
Biora Therapeutics Shares Progress on Smaller BioJet™ - GlobeNewswire
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting - StockTitan
Biora Therapeutics Inc’s results are impressive - US Post News
Market Highlights: Biora Therapeutics Inc (BIOR) Ends on a Low Note at 0.55 - The Dwinnex
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting - The Manila Times
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the - GlobeNewswire
Biora Therapeutics enacts reverse stock split, adjusts shares By Investing.com - Investing.com Australia
Biora Therapeutics enacts reverse stock split, adjusts shares - Investing.com India
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium - The Manila Times
Biora Therapeutics Announces Award-Winning Abstract to be - GlobeNewswire
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024 - Yahoo Finance
Biora Therapeutics Inc’s Market Journey: Closing Weak at 0.59, Down -9.63 - The Dwinnex
Biora Therapeutics Inc Inc. (BIOR) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Biora Therapeutics secures additional $4 million financing - Investing.com India
Biora Therapeutics secures additional $4 million financing By Investing.com - Investing.com UK
Biora Therapeutics Achieves ISO 13485 Certification - GlobeNewswire
A History of Outperforming Analyst Forecasts and Beating the Odds: Biora Therapeutics Inc (BIOR) - SETE News
Biora Therapeutics Announces Positive Nasdaq Listing Decision - GlobeNewswire
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Biora Therapeutics secures new financial agreements - Investing.com India
BIOR: Second Quarter Results - Yahoo Finance
Biora Therapeutics, Inc. (NASDAQ:BIOR) Forecasted to Post Q3 2024 Earnings of ($0.42) Per Share - Defense World
BIOR’s Stock Woes: Down -20.37% in 6 Months, Down -20.37% in Just 5 Days - The InvestChronicle
Biora Therapeutics Second Quarter 2024 Earnings: EPS: US$0.18 (vs US$1.47 loss in 2Q 2023) - Yahoo Finance
Biora Therapeutics (NASDAQ:BIOR) Receives “Buy” Rating from HC Wainwright - Defense World
Biora Therapeutics, Inc. (NASDAQ:BIOR) Q2 2024 Earnings Call Transcript - Insider Monkey
Biora Therapeutics maintains stock target after strong Q2 results By Investing.com - Investing.com UK
Earnings call: Biora Therapeutics reports progress on BT-600 and BioJet platforms - Investing.com
Biora Therapeutics Inc (BIOR) Q2 2024 Earnings Call Transcript H - GuruFocus.com
BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024 - MSN
Biora Therapeutics, Inc. (BIOR) Q2 2024 Earnings Call Transcript - Seeking Alpha
Biora Therapeutics Announces Funding Agreement with Existing Investors - GlobeNewswire
Biora Therapeutics Restructures Debt and Issues New Securities - TipRanks
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results - GlobeNewswire
Finanzdaten der Biora Therapeutics Inc-Aktie (BIOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):